In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) closed at $493.22 in the last session, up 2.10% from day before closing price of $483.07. In other words, the price has increased by $2.10 from its previous closing price. On the day, 1.5 million shares were traded.
Ratios:
We take a closer look at REGN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.17. For the most recent quarter (mrq), Quick Ratio is recorded 4.03 and its Current Ratio is at 4.93. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
On May 30, 2025, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform but kept the price unchanged to $662.
Citigroup Upgraded its Neutral to Buy on May 14, 2025, while the target price for the stock was maintained at $700.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 01 ’24 when McCourt Marion sold 1,000 shares for $844.61 per share. The transaction valued at 844,610 led to the insider holds 12,931 shares of the business.
MARION E MCCOURT bought 1,000 shares of REGN for $844,610 on Nov 01 ’24. On Oct 01 ’24, another insider, RYAN ARTHUR F, who serves as the Director of the company, sold 100 shares for $1048.78 each. As a result, the insider received 104,878 and left with 17,582 shares of the company.
Valuation Measures:
As of this moment, Regeneron’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.55, and their Forward P/E ratio for the next fiscal year is 12.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 9.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.78 while its Price-to-Book (P/B) ratio in mrq is 1.82.
Stock Price History:
Over the past 52 weeks, REGN has reached a high of $1211.20, while it has fallen to a 52-week low of $476.49. The 50-Day Moving Average of the stock is -14.15%, while the 200-Day Moving Average is calculated to be -36.33%.
Shares Statistics:
A total of 106.40M shares are outstanding, with a floating share count of 104.06M. Insiders hold about 3.61% of the company’s shares, while institutions hold 87.16% stake in the company.
